Antiviral activity against HIV1 pseudotyped EBOV infected in HEK293T cells assessed as reduction in virus induced cytopathic effect by luciferase reporter gene assay
Antiviral activity against HIV1 pseudotyped MARV infected in HEK293T cells assessed as reduction in virus induced cytopathic effect by luciferase reporter gene assay
Antiviral activity against HIV1 pseudotyped VSV infected in HEK293T cells assessed as reduction in virus induced cytopathic effect by luciferase reporter gene assay
Antiviral activity against HIV1 pseudotyped EBOV infected in BALB/c mouse at 100 ug, iv and ip measured at day 4 by bioluminescence assay relative to control
Antiviral activity against HIV1 pseudotyped MARV infected in BALB/c mouse at 100 ug, iv and ip measured at day 4 by bioluminescence assay relative to control
Antiviral activity against HIV1 pseudotyped EBOV infected in HEK293T cells assessed as inhibition of late stage viral entry at 25 uM treated for 1 hr before infection measured after 72 hrs by luciferase reporter gene assay relative to control
Antiviral activity against HIV1 pseudotyped EBOV infected in HEK293T cells assessed as inhibition of late stage viral entry at 25 uM treated during infection measured after 72 hrs by luciferase reporter gene assay relative to control
Antiviral activity against HIV1 pseudotyped EBOV infected in HEK293T cells assessed as inhibition of late stage viral entry at 25 uM treated for 1 hr post infection measured after 72 hrs by luciferase reporter gene assay relative to control